SCHEMBL25713155

SCHEMBL25713155

Cc1ccc2cc3cccn3cc2c1-c1nc2ccccc2n1-c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.43
HTT P42858 1/20 0.43
RPS6KB1 P23443 3/20 0.40
ROCK1 Q13464 2/20 0.40
PRKACA P17612 1/20 0.40
GSK3B P49841 1/20 0.40
ESR1 P03372 3/20 0.39
ESR2 Q92731 3/20 0.39
RECQL P46063 1/20 0.39
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
TLR9 Q9NR96 1/20 0.38
GSR P00390 1/20 0.37
HDAC1 Q13547 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
ALDH1A1 P00352 2/20 0.36
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25712678 0.91 MAPK1 (0.43) MAPK1HTTRPS6KB1ROCK1PRKACA
SCHEMBL20980492 0.82 RECQL (0.48) MAPK1HTTRPS6KB1ROCK1PRKACA
SCHEMBL25713147 0.77 CYP3A4 (0.37) MAPTALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL24160885 0.76 KDM4E (0.45) MAPK1HTTRPS6KB1GSK3BMEN1
SCHEMBL20980484 0.75 RECQL (0.48) MAPK1HTTRPS6KB1ROCK1PRKACA
SCHEMBL12107125 0.71 MAPK1 (0.54) MAPK1HTTRPS6KB1ROCK1PRKACA
SCHEMBL804817 0.70 MAPK1 (0.66) MAPK1HTTRPS6KB1ROCK1PRKACA
SCHEMBL24160886 0.70 MAPT (0.39) ESR1ESR2MAPTHDAC1HDAC8
SCHEMBL10041263 0.70 MAPK1 (0.51) MAPK1HTTRPS6KB1ROCK1PRKACA
SCHEMBL14160945 0.69 MAPK1 (0.49) MAPK1HTTRPS6KB1ROCK1PRKACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685756-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11685756-B2 Organic electroluminescent materials and devices OCIAD1, OCIAD2, OPRD1 MAPK1 2468/4885HTT 2117/4885RPS6KB1 4142/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.